Valeo Pharma (VPH.C) has gotten their their Hesperco flavonoid formulation on shelves at over 300 stores under the Loblaws brand, including Loblaws, Dominion, Zehs, Fortinios, Your Independent Grocer and…
Pharmaceuticals
I’ve said it before but I will say it again. Cancer is a bitch. In fact, this group of diseases is a leading cause of death worldwide, accounting for…
$901.372M Market Capitalization Mind Medicine Inc. (MNMD.Q) today announced the initiation of a Phase 2a proof-of-concept (POC) trial of lysergic acid diethylamide (LSD) in adult patients with attention deficit…
Tetra Bio-Pharma (TBP.T) (“Tetra”) is a biopharmaceutical company focused on cannabinoid-derived drug discovery and development. The Company has an FDA and Health Canada cleared clinical program intended to bring…
Friday was an epic day for Stock Markets. Red across the board, and many major support levels being taken out. Why? Fear of a new variant. Omicron out of…
Looking at the charts of the Psychedelics sector, they can best be described as a mixed bag. Just like Cannabis, shroom stocks are taking a hit. This could just…
There are many cases in today’s market of investors allowing their mob mentality to inefficiently price securities in the public auction market. Sir John Templeton, speaking on market volatility…
Filament Health Corp. (FH.NE) announced today that it has entered into a co-development and exclusive licensing agreement with EntheoTech Bioscience Inc. “Our partnership with EntheoTech showcases our commitment to…
Valeo Pharma Inc. (VPH.C) announced today that it has successfully entered into a Product Listing Agreement (PLA) with the Quebec Minister of Health. According to this agreement, the Company…
Long time readers have been aware that, for some time, Equity.Guru has been a supporter of Canntab Therapeutics (PILL.C), but have been frustrated watching the company being slow on…